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Abstract
Introduction. Stenotrophomonas maltophilia has emerged as one of the most common multi- drug- resistant pathogens isolated 
from people with cystic fibrosis (CF). However, its adaptation over time to CF lungs has not been fully established.
Hypothesis. Sequential isolates of S. maltophilia from a Brazilian adult patient are clonally related and show a pattern of adap-
tation by loss of virulence factors.
Aim. To investigate antimicrobial susceptibility, clonal relatedness, mutation frequency, quorum sensing (QS) and selected viru-
lence factors in sequential S. maltophilia isolates from a Brazilian adult patient attending a CF referral centre in Buenos Aires, 
Argentina, between May 2014 and May 2018.
Methodology. The antibiotic resistance of 11 S. maltophilia isolates recovered from expectorations of an adult female with CF 
was determined. Clonal relatedness, mutation frequency, QS variants (RpfC–RpfF), QS autoinducer (DSF) and virulence factors 
were investigated in eight viable isolates.
Results. Seven S. maltophilia isolates were resistant to trimethoprim–sulfamethoxazole and five to levofloxacin. All isolates 
were susceptible to minocycline. Strong, weak and normomutators were detected, with a tendency to decreased mutation rate 
over time. XbaI PFGE revealed that seven isolates belong to two related clones. All isolates were RpfC–RpfF1 variants and DSF 
producers. Only two isolates produced weak biofilms, but none displayed swimming or twitching motility. Four isolates showed 
proteolytic activity and amplified stmPr1 and stmPr2 genes. Only the first three isolates were siderophore producers. Four iso-
lates showed high resistance to oxidative stress, while the last four showed moderate resistance.
Conclusion. The present study shows the long- time persistence of two related S. maltophilia clones in an adult female with CF. 
During the adaptation of the prevalent clones to the CF lungs over time, we identified a gradual loss of virulence factors that 
could be associated with the high amounts of DSF produced by the evolved isolates. Further, a decreased mutation rate was 
observed in the late isolates. The role of all these adaptations over time remains to be elucidated from a clinical perspective, 
probably focusing on the damage they can cause to CF lungs.
InTRoduCTIon
Stenotrophomonas maltophilia, an environmental non- 
fermentative Gram- negative bacterium, has been classified 
by the World Health Organization as one of the leading 
drug- resistant pathogens in hospitals worldwide [1]. Respira-
tory tract colonization by S. maltophilia is commonly seen 
in patients suffering from cystic fibrosis (CF), the most 
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frequently observed severe autosomal recessive genetic 
disease in Caucasians [2–4].
Several worldwide CF centres have reported that the 
prevalence of S. maltophilia has increased in recent decades, 
reaching 10 to 18% of patients with CF [5]. However, its 
contribution to lung damage has not been fully established 
[6]. Nevertheless, it was demonstrated that chronic coloniza-
tion/infection with S. maltophilia is an independent risk factor 
for pulmonary exacerbation and has been associated with a 
specific immune response and with a threefold increased risk 
of mortality or lung transplantation in CF patients [7, 8]. 
Furthermore, the pathogenic role of S. maltophilia in patients 
with CF is suggested by its ability to form biofilms on the 
CF- derived epithelial monolayer and its contribution to the 
inflammatory process in a murine model of acute respiratory 
infection that leads to a compromised respiratory function 
and death [9].
Factors that have been involved in the virulence of S. malt-
ophilia include, among others, biofilm formation, extracel-
lular enzymes such as proteases, siderophores and resistance 
to oxidative stress [10–14]. The quorum sensing (QS) system 
of S. maltophilia is based on the diffusible signal factor (DSF). 
DSF production and detection depends on the rpf regula-
tion of pathogenicity factors gene cluster, which encodes the 
synthase RpfF and the RpfC/RpfG two- component system, 
responsible for perception and transduction of the DSF signal 
[15]. Huedo et al. described two variants of the rpf cluster in 
S. maltophilia strains: the RpfC–RpfF1 variant strains produce 
DSF, while the RpfC–RpfF2 variant strains only do so in the 
presence of DSF producers [15].
Treatment of S. maltophilia infections is difficult because of 
its intrinsic multi- drug resistance (including carbapenems) 
and its ability to form biofilms [6, 16]. Even though trimetho-
prim–sulphamethoxazole (SXT) is the first- line drug against 
S. maltophilia infections [17, 18], worldwide emergence of 
SXT resistance has been reported [17], and furthermore, high 
rates of resistance were observed in S. maltophilia isolates 
from patients with CF [19, 20]. Other drugs with activity 
against S. maltophilia are minocycline and levofloxacin [21].
Many pathogens alter their phenotype and genotype during 
chronic infection in response to selection pressures. Bacte-
rial adaptation to survive in the CF lung has predominantly 
been studied for Pseudomonas aeruginosa and Staphylococcus 
aureus [22–24]. Since the adaptation strategies of S. malt-
ophilia isolates have been sparsely examined [2, 3, 9, 25, 26], 
the longitudinal analysis based on sequential isolates in a 
patient with CF from our study will provide an opportunity 
to examine the modifications that S. maltophilia may undergo 
during the course of chronic lung colonization.
The aim of this work was to investigate antimicrobial suscepti-
bility, clonal relatedness, mutation frequency, DSF production, 
the presence of RpfC–RpfF variants and selected virulence 
factors in sequential S. maltophilia isolates from a Brazilian 
adult patient attending a CF referral centre in Buenos Aires, 
Argentina, between May 2014 and May 2018.
METHodS
Bacterial isolates and culture conditions
A total of 11 S. maltophilia isolates were recovered from 
sputum samples of an adult Brazilian female with CF between 
May 2014 and May 2018 at Instituto de Investigaciones en 
Microbiología y Parasitología Médica, Universidad de Buenos 
Aires, Consejo Nacional de Investigaciones Científicas y 
Tecnológicas (IMPaM, UBA- CONICET), Buenos Aires, 
Argentina (Table 1). Isolates were identified as S. maltophilia 
by matrix- assisted laser desorption/ionization time- of- 
flight mass spectrometry (MALDI- TOF MS). S. maltophilia 
K279a, whose genome has been fully sequenced (GenBank: 
AM743169.1), was used as a reference strain [27]. S. malt-
ophilia D457 (GenBank: HE798556.1) was used as a control 
for the RpfC–RpfF2 variant [28]. S. maltophilia SmEL06, 
a trimethoprim–sulfamethoxazole- resistant CF isolate 
recovered from a chronically colonized paediatric patient 
in Hospital General de Niños ‘Pedro de Elizalde’, Argentina, 
positive for intl1, qacEΔ1- sul1 and sul1 genes, was used as a 
control for the detection of resistance determinants for SXT 
[29]. Xanthomonas campestris pv. campestris (Xcc) 8004 and 
Xcc 8523 (rpfF mutant) were used in the DSF bioassay [14, 30]. 
Isolates were kept frozen at −20 °C in 15 % glycerol. Before use, 
bacteria were cultured on tryptone soya agar (TSA; Oxoid 
Ltd) for 24 h at 35 °C. Unfortunately, bacterial cells could not 
be recovered from the Sm1324, Sm1331 and Sm1332 samples 
(Table 1). Unless stated otherwise, all cultures were grown in 
tryptone soya broth (TSB; Oxoid Ltd) and incubated at 35 °C. 
When indicated, cultures were aerated during growth on a 
water bath shaker at 200 r.p.m.
Susceptibility
Antimicrobial susceptibility was assessed using the disc diffu-
sion method according to the Clinical and Laboratory Stand-
ards Institute (CLSI) recommendations [31]. The testing was 
performed on Mueller–Hinton agar plates with minocycline, 
levofloxacin (LEV) and trimethoprim–sulfamethoxazole 
(SXT) discs (Britania). Escherichia coli ATCC 25922 and 
P. aeruginosa ATCC 27853 were used as quality control 
strains. The breakpoints used were those recommended by 
the CLSI for S. maltophilia.
detection of resistance determinants for SXT
The presence of class 1 and class 2 integrons as well as 
qacEΔ1- sul1, sul1 and dfrA1 genes was tested by PCR using 
total DNA (extracted by the boiling method) as a template. 
Table 2 shows the primers, amplicon sizes and references 
corresponding to the detection of resistance determinants for 
SXT. The PCR reactions for detection of class 1 and class 2 
integrons were performed in a total volume of 25 ul containing 
0.2 mM each dNTP, 1 U of GoTaq DNA polymerase (Promega) 
in 5× GoTaq reaction buffer, 10 pmol of each primer (Table 2) 
and 5 µl of template DNA. The thermocycler conditions for 
the detection of the intI1 gene were: 5 min at 95 °C, followed 
by 35 cycles of 45 s at 94 °C, 1 min at 64 °C and 90 s at 72 °C, 
with a final extension of 10 min at 72 °C. For the detection 
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of the intI2 gene, the thermocycler conditions were: 5 min at 
95 °C, followed by 30 cycles of 1 min at 94 °C, 1 min at 52 °C 
and 1 min at 72 °C, with a final extension of 10 min at 72 °C. 
The PCR reactions for the detection of the qacEΔ1- sul1, 
sul1 and dfrA1 genes were performed in a 25 µl final volume 
containing 1 U of GoTaq DNA polymerase (Promega) in 5× 
GoTaq reaction buffer, dimethyl sulfoxide 10 %, 0.4 mM of 
each dNTP, 10 pmol of the corresponding primers (Table 2) 
and 3 µl of bacterial DNA. The amplification profile was 
5 min at 95 °C, 30 cycles of 1 min at 95 °C, 1 min at 60 °C (for 
qacEΔ1- sul1), 68 °C (for sul1) or 55 °C (for dfrA1), and 1 min 
at 72 °C, followed by a final extension of 10 min at 72 °C. For 
PCR negative controls, DNA template was substituted with 
sterile distilled water. The strains used as a positive control 
in the PCR reaction were Serratia marcescens SCH909 [32] 
(positive control intI1 and dfrA1), Salmonella enterica serovar 
Infantis S21 [33] (AJ311891, positive control sul1 and 3′CS 
region) and E. coli 8157 EU780012.1 [34] (positive control 
intI2). S. maltophilia SmEL06, a SXT- resistant CF isolate 
recovered from a chronically colonized paediatric patient in 
Argentina that was positive for the intl1, qacEΔ1- sul1 and sul1 
genes, was included in the PCR reaction for the detection of 
resistance determinants for SXT [29]. K279a, a strain that is 
sensitive to SXT, was also included [27]. PCR amplifications 
were carried out in a MyCycler thermal cycler (Bio- Rad). 
PCR- amplicons were resolved in 1.5 % agarose gels containing 
ethidium bromide and visualized under UV light.
Mutation frequency assay
Rifampicin resistance mutation frequency was determined 
as described previously [35]. Independent triplicate Luria 
Bertani (LB) broth cultures of each S. maltophilia isolate 
were grown with agitation. After overnight incubation total 
viable cell count was determined by plating on LB agar 
plates and the cell pellet from 1 ml culture was inoculated 
on LB/rifampicin plates (250 μg ml−1).The spontaneous 
rifampicin- resistant mutation frequency was calculated by 
dividing the mean number of rifampicin- resistant colonies 
by the total viable cell count. S. maltophilia isolates were 
classified into four categories based on their mutation 
frequencies (f): hypomutators (f≤8×10−9), normomutators 
(8×10−9<f<4×10−8), weak mutators (4×10−8≤f<4×10−7) and 
strong mutators (f≥4×10−7) [35].
Phenotypic and genotypic typing
Phenotypic typing of the isolates was performed using 
API20NE test kits (bioMérieux, France) according to the 
manufacturer’s instructions. Genotypic typing was assessed 
by RAPD- PCR as described previously [36]. Briefly, ampli-
fication reactions were performed in a 25 µl final volume 
containing 2 U of GoTaq DNA polymerase (Promega) in 
5× GoTaq reaction buffer, 4 mM MgCl2, dimethyl sulfoxide 
10 %, 0.4 mM of each dNTP, 50 pmol of primer ERIC-2 
(5′- AAGT AAGT GACT GGGG TGAGCG-3′) and 3 µl of 
Table 1. Characteristics of 11 sequential S. maltophilia isolates
CF isolates Date of sample Co- isolated micro- organisms Antibiotic resistance API 20NE biocode Mutation frequency 
(f)
Sm1318 26 May 2014 C. albicans SXT II (S) 8.10×10−7±0.16
Sm1321 8 August 2014 C. albicans SXT II (N) 3.58×10−8±0.09
Sm1324 4 November 2014 – SXT
LEV
nd nd
Sm1326 24 February 2015 Streptococcus australis LEV I (W) 4.19×10−8±0.21
Sm1331 13 November 2015 C. albicans LEV nd nd
Sm1332 25 February 2016 C. albicans
Streptococcus haemolyticus
SXT nd nd
Sm1336 12 July 2016 C. albicans
Klebsiella pneumoniae
LEV II (S) 5.34×10−7±0.11
Sm1340 1 December 2016 K. pneumoniae LEV III (W) 7.55×10−8±0.07
Sm1342 9 July 2017 C. albicans SXT I (S) 8.68×10−7±0.22
Sm1346 11 December 2017 C. albicans
Streptococcus sanguinis group
SXT II (W) 1.40×10−7±0.18
Sm1347 24 May 2018 – SXT III (N) 3.98×10−8±0.09
The antimicrobial susceptibility for minocycline, trimethoprim–sulfamethoxazole (SXT) and levofloxacin (LEV) was assessed using the disc 
diffusion method according to CLSI recommendations. API20NE biocodes were determined based on the production of β-galactosidase and 
cytochrome oxidase: I, 0452341 (−/−); II, 0452345 (−/+); and III, 0472345 (+/+). Rifampicin resistance mutation frequency (f) was determined as 
described in the Methods section and the isolates were classified as normomutators (8×10−9<f<4×10−8), weak mutators (4×10−8≤f<4×10−7) or 
strong mutators (f≥4×10−7). S. maltophilia K279a was used as control (N; f=3.83×10−8±0.04).
CF, cystic fibrosis; nd, not determined.
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bacterial DNA. PCR product patterns were considered 
identical when the positions of all bands matched, regard-
less of band intensity [37]. Isolates were also genotyped by 
PFGE using the restriction enzyme XbaI (Thermo Fisher 
Scientific) as reported previously [36]. Gels were stained 
with ethidium bromide and digitized (Molecular Imager Gel 
Doc XR, Bio- Rad). The dendrogram of PFGE profiles was 
constructed using UPGMA cluster analysis with Treecon 
software (http:// bioinformatics. psb. ugent. be). Strains were 
defined as having a clonal relationship if they possessed 
≥85 % similarity to the PFGE profiles [38].
Screening of clusters RpfC–RpfF1 and RpfC–RpfF2
The presence of the QS system variants, RpfC–RpfF1 and 
RpfC–RpfF2, was investigated by PCR. Table 2 shows the 
primers, amplicon sizes and references corresponding to 
the detection of these two variants. The amplification reac-
tions were performed in a 25 µl final volume containing 
1 U of GoTaq DNA polymerase (Promega) in 5× GoTaq 
reaction buffer, dimethyl sulfoxide 10 %, 0.4 mM of each 
dNTP, 10 pmol of the each primer (Table  2) and 3 µl of 
bacterial DNA. The thermocycler conditions were 5 min 
at 95 °C, 30 cycles of 1 min at 95 °C, 1 min at 60 °C and 90 s 
at 72 °C, followed by a final extension of 10 min at 72 °C. 
The strains used as a positive control in the PCR reaction 
were S. maltophilia K279a (positive control rpfC–rpfF1) and 
S. maltophilia D456 (positive control rpfC–rpfF2) [28]. The 
length of the amplification products, analysed by electro-
phoresis in a 1.5 % agarose gel, was used to discriminate 
between variants.
detection of narG, stmPr1 and stmPr2 genes
The presence of narG, stmPr1 and stmPr2 genes was deter-
mined by PCR using a simple boiling DNA extraction as 
a template. Table  2 shows the primers, amplicon sizes 
and references corresponding to the detection of these 
virulence factors. All primers were designed based on the 
genomic sequence of K279a (GenBank: AM743169.1). 
Amplification reactions were performed in a 25 µl final 
volume containing 1 U of GoTaq DNA polymerase 
(Promega) in 5× GoTaq reaction buffer, dimethyl sulfoxide 
10 %, 0.4 mM of each dNTP, 10 pmol of the corresponding 
primers (Table 2) and 3 µl of bacterial DNA. The ampli-
fication profile was 5 min at 95 °C, 30 cycles of 1 min at 
95 °C, 30 s at 50 °C (for narG), 55 °C (for stmPr1) or 48 °C 
(for stmPr2) and 1 (stmPr2 and narG) or 2 min (stmPr1) 
at 72 °C, followed by a final extension of 10 min at 72 °C. 
S. maltophilia K279a was used as a positive control in he 
PCR reaction for narG, stmPr1 and stmPr2 [12, 36]. The 
amplification products were analysed by electrophoresis 
in a 1.5 % agarose gel.
Table 2. Oligonucleotides used to examine the presence of integrons and virulence factors
Target/gene Primers Sequence (5′−3′) Amplicon size (bp) Reference
Class 1 integrase/intI1 Sulpro3 GCCTGACGATGCGTGGA Variable region of integrons [17, 32]
Sul1r TTTGAAGGTTCGACAGC
Class 2 integrase/intI2 Inti 2 F GCAAATGAAGTGCAACGC 495 [17]
Inti 2 R ACACGCTTGCTAACGATG
3’CS region/qacEΔ1- sul1 qacEΔ1F ATCGCAATAGTTGGCGAAGT 798 [33]
Sul1B GCAAGGCGGAAACCCGCGCC
Sul1/sul1 Sul1F CTTCGATGAGAGCCGGCGGC 437 [33]
Sul1B GCAAGGCGGAAACCCGCGCC
DfrA1/dfrA1 dfrA1- F AGCTGTTCACCTTTGGC 180 [17, 32]
dfrA1- R CCTGAAATCCCCAGCAA
NarG/narG narG- F GGCTTGAGCACGATGCGGGT 623 [36]
narG- R GTGGGCAAGGAGCACGAGGC
StmPr1/stmPr1 StmPr1- F GCCGCAGTGTTGGTTCGATCCA 1621 [12]
StmPr1- R CAGTTCTCGGTGCACGGCTCTT
StmPr2/stmPr2 StmPr2- F CGTGCCAGCTTCTCCAACTA 570 This study
StmPr2- R AGGACTGTTGATGGTGCAGG
RpfC/rpfC RpfC- F TGTTCGGCTGGCTGCTGT 1019
(rpfC–rpfF1)
[28]
RpfC- R GGCCAGCACTTCGGTCAT 450
(rpfC–rpfF2)
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nitrate reduction
The ability of the isolates to reduce nitrate was assessed using 
the API 20NE system.
Biofilm formation
Biofilm formation was evaluated using a static microtitre plate 
model and standardized cultures as described previously [10]. 
After 24 and 48 h of incubation in TSB at 35 °C, biofilms were 
stained with crystal violet (CV) and total biomass (attached 
cells and extracellular matrix) was quantified by measuring 
the OD546 of ethanol- dissolved CV using a FlexStation 3 plate 
reader (Molecular Devices). The cut- off (ODc) was defined as 
three standard deviations above the mean OD of the negative 
control (uninoculated medium). Each isolate was assayed in 
octuplicate and classified as strong (OD >4×ODc), moderate 
(2×ODc<OD≤4×ODc), weak (ODc <OD≤2×ODc) and non- 
biofilm producer (OD ≤ODc) [39]. The levels of CV staining 
were also expressed relative to the final culture density meas-
ured prior to biofilm assay (OD546 CV/OD546 growth ratio) 
to avoid variations due to differences in bacterial growth [10].
For the following assays, each S. maltophilia isolate was 
incubated at 35 °C with agitation (200 r.p.m.) in the corre-
sponding media and after the incubation period (specified 
in the corresponding reference) the final culture density was 
adjusted with fresh media to an OD546 of 1.00 in order to avoid 
variations due to differences in bacterial growth.
Motility assays
Swimming and twitching motility assays were performed in 
triplicate according to Rashid and Kornberg [40], with some 
modifications. Briefly, motility plates were inoculated with 
bacteria from standardized overnight TSB cultures with a 
sterile toothpick. Swimming agar was surface- inoculated 
and after incubation at 30 °C for 24 h, the growth zone was 
measured in millimetres. Twitching plates were inoculated to 
the bottom of the Petri plate, incubated at 35 °C for 48 h, and 
examined for a haze zone of growth at the interface between 
the agar and the Petri plate. Then, the agar was removed, the 
plate was stained with CV (0.1 %) for 30 min and twitching 
activity was measured in milimetres.
Protease production
The proteolytic activity was visualized on nutrient agar (Difco) 
supplemented with 1 % skimmed milk powder. Quantification 
was performed by placing a 40 µl volume of S. maltophilia 
standardized cultures in 7.2 mm diameter wells previously 
cut into the agar plate. The plates were incubated for 24 h and 
the diameter of the zones of hydrolysis was measured [10]. 
The proteolytic activity was also examined after incubation 
for 48 and 72 h.
Siderophore production
The production of siderophores was determined by a modi-
fied chrome azurol S (CAS) agar assay as described previously 
[13]. Standardized suspensions were stab- inoculated onto 
CAS agar plates and incubated at 35 °C for 48 h. Siderophore 
production was recorded as the diameter of the orange halo 
produced by the colony. Each isolate was classified as a weak 
(4.0–5.9 mm), moderate (6.0–8.9 mm) or strong siderophore 
producer (>9 mm) [36].
Sensitivity to oxidative stress
Sensitivity to hydrogen peroxide was determined using the 
disc assay [10]. Briefly, S. maltophilia 24 h TSB cultures were 
standardized and 100 µl aliquots were spread on TSA plates. 
Sterile Whatman filter paper discs (7 mm diameter) were 
impregnated with 3 µl of 12 % H2O2 and placed in tripli-
cate on each plate. After incubation at 35 °C for 24 h, the 
diameter of the zone of growth inhibition around the discs 
was measured. The resistance of each isolate to hydrogen 
peroxide was classified as: low (>18 mm), moderate 
(16–18 mm), or high (<16 mm) [36].
dSF production
DSF production was assayed, as described previously, by 
measuring the restoration of endoglucanase activity to the rpfF 
mutant Xcc 8523 by extracts from culture supernatants [14]. 
The diameters of zones of carboxymethyl cellulose (CMC; 
Sigma- Aldrich) hydrolysis, produced by 50 µl of extract, were 
measured and converted to relative endoglucanase units with 
a standard curve constructed using dilutions of a standard 
of cellulase I (Sigma Aldrich). One unit of endoglucanase 
was defined as the amount that gave a hydrolysis zone with a 
diameter of 12 mm.
Statistical analysis
Experiments were performed on three different occasions, 
at least in triplicate. Statistical analysis was performed using 
GraphPad Prism version 6.0 (GraphPad Software, www. 
graphpad. com). Results were analysed using one- way analysis 
of variance (ANOVA) with Dunnett’s post- test, and differ-
ences were considered significant at P values <0.05.
RESuLTS And dISCuSSIon
A total of 11 S. maltophilia isolates, identified by MALDI-
 TOF MS, were recovered from he expectorations of an adult 
female with CF between May 2014 and May 2018. The patient 
attended the Instituto de Investigaciones en Microbiología 
y Parasitología Médica (IMPaM, UBA- CONICET), Buenos 
Aires, Argentina, from December 2006. P. aeruginosa and 
Burkholderia cepacia complex were recovered intermittently 
from the patient between December 2006 and November 
2009. P. aeruginosa was eradicated in 2010 and B. cepacia 
complex in 2011. Then, negative cultures were observed 
until May 2014 when S. maltophilia was isolated for the 
first time and showed persistence over a 4- year period. 
In accordance with previous reports [8], polymicrobial 
cultures were obtained from 9/11 samples, with Candida 
albicans (7/9, Table 1) being the most frequent co- isolated 
micro- organism.
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Susceptibility
Table  1 summarizes the resistance data. Seven out of 11 
S. maltophilia isolates showed resistance to SXT and 5 were 
resistant to levofloxacin, while only Sm1321 had intermediate 
susceptibility to this fluoroquinolone. In accordance with 
previous reports, all sequential isolates were susceptible to 
minocycline [21, 36].
detection of resistance determinants to SXT
Previously, we had found that class 1 integrons increase 
minimum inhibitory concentrations (MICs) for SXT in epide-
miologically unrelated S. maltophilia strains from our country 
[17]. Further, worldwide emergence of SXT resistance has 
been reported in S. maltophilia isolates from patients with 
CF [20]. The spread of resistance is related to dihydropteroate 
synthase (sul1 and sul2) genes and to dihydrofolate reductase 
(dfrA) gene cassettes usually located in the variable region of 
class 1 and class 2 integrons [17, 18]. In this study, the pres-
ence of class 1 and 2 integrons was examined by cartography 
of integrons as described previously [41] using PCR in the 
five SXT- resistant S. maltophilia isolates (Table 2). None of 
the isolates, or the SXT- sensitive strain K279a, were positive 
for qacEΔ1- sul1, sul1, dfrA1 and integrase genes (intI1 and 
intI2) under the described PCR amplification conditions (Fig. 
S1, available in the online version of this article). Although all 
primers were designed while taking the conserved regions of 
the different targets into account, it is important to note that 
specific genes were examined by PCR, given that negative 
results can be interpreted not only as the absence of the gene 
but also as insufficient complementarity to the primer used. 
However, we have recently reported that two SXT- resistant 
S. maltophilia CF isolates recovered from a chronically 
colonized paediatric patient in Argentina were positive for 
class 1 integrase, qacEΔ1- sul1 and sul1 genes [29]. One of 
these isolates, SmEL06, was included in the PCR assays, 
which accurately detected the three mentioned SXT resist-
ance determinants (Fig. S1). Thus, our results suggest that 
other antimicrobial resistance mechanisms unrelated to the 
acquisition of multidrug- resistant integrons are emerging in 
S. maltophilia strains isolated from patients with CF, which 
should be studied in the near future, since SXT continues to 
be considered as the antimicrobial therapy of choice for severe 
S. maltophilia infections [18].
Evaluation of mutation frequency
Microbial populations of S. maltophilia, as well as other 
bacterial species in CF lungs, are exposed to a challenging 
environment and repeated antibiotic treatments that favour 
the emergence of mutator phenotypes [3, 42]. The emergence 
and adaptation of strong mutators in S. maltophilia within the 
CF lungs is not well established, since although two groups 
identified a decreased mutation rate over time [2, 9], another 
group found a trend toward increased mutation rates in 
isolates from a patient [3]. We analysed this capacity in our 
isolates in order to contribute to this controversial role in 
S. maltophilia. Table 1 shows that, based on the spontaneous 
rifampicin- resistant mutation frequency, three CF S. malt-
ophilia isolates were classified as strong mutators (Sm1318, 
Sm1336 and Sm1342), another three as weak mutators 
(Sm1326, Sm1340 and Sm1346), and the remaining two 
(Sm1321 and Sm1347), as well as the control strain K279a, 
as normomutators [35]. Although our sampling number is 
small (n=8) the prevalence of strong mutators (37.5 %) is close 
to that described in previous reports [3]. In accordance with a 
previously reported tendency of most S. maltophilia clonally 
related genotypes to vary their mutation frequency over time 
and become less mutable as a strategy for persistence in the 
CF lung [2, 9], we observed a tendency towards a decreased 
mutation rate over time (Table 1).
Phenotypic and genotypic typing
Biochemical typification of the S. maltophilia sequential 
isolates performed using API20NE showed three biotypes: 
I (Sm1326 and Sm1342), II (Sm1318, Sm1321, Sm1336 and 
Sm1346) and III (Sm1340 and Sm1347), based on the produc-
tion of β-galactosidase and cytochrome oxidase (Table 1). 
Fig. 1. Genotypic typing of sequential S. maltophilia isolates. (a) RAPD- PCR amplification patterns obtained with primer ERIC-2. M, 1 Kb 
molecular weight marker. (b) Phylogenetic analysis of XbaI PFGE profiles. The dendrogram of PFGE profiles of eight S. maltophilia 
isolates was constructed using UPGMA cluster analysis with Treecon software. Isolates were defined as having a clonal relationship if 
they possessed ≥85 % similarity to the PFGE profiles.
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Even though S. maltophilia is usually oxidase- negative, anal-
ysis of 766 isolates showed that 20 % were oxidase- positive. 
Thus, S. maltophilia should be considered to be variable with 
respect to oxidase activity [43].
Genotypic typing assessed by RAPD PCR, using primer 
ERIC-2, revealed that all the isolates shared a unique finger-
print (Fig. 1). Then, XbaI PFGE was conducted to evaluate 
the relationship among these indistinguishable isolates. This 
technique indicated that seven isolates belonged to two related 
clones, while Sm1326 had a different profile (Fig. 1). Two 
isolates of one of these clones, Sm1340 and Sm1342, presented 
indistinguishable PFGE DNA banding patterns, although 
characterized by different susceptibility to antimicrobials, 
API20NE biocodes and mutation frequency (Table 1).
Presence of virulence factors
The CF S. maltophilia isolates were characterized by the pres-
ence and/or expression of selected virulence determinants.
Biofilm formation in microtitre plates was evaluated at 24 
and 48 h of incubation. Growth was determined by measuring 
the OD546 prior to evaluating biofilm formation proficiency 
by CV staining. Fig.  2a (left panel) shows that at 24 h of 
incubation CF isolates presented poor bacterial growth, with 
ODs ranging from 0.163 to 0.411, and none of them formed 
biofilms (Fig. 2a, right panel). Improvement of growth was 
registered at 48 h, when most isolates reached mean OD546 
readings of approximately 0.300, except for Sm1326 and 
Sm1336, which attained an OD546 of 0.652 and 0.512, respec-
tively. Only two CF isolates, Sm1321 and Sm1326, formed 
biofilms after 48 h of incubation. Even though these isolates 
had different growth proficiency, they were both classified 
as weak biofilm producers. In contrast, the positive control 
K279a showed growth ODs of 1.347 and 1.227 at 24 and 
48 h, respectively, and formed strong biofilms at both times. 
In order to avoid variations due to differences in bacterial 
growth, we also expressed biofilm formation results as OD546 
CV/OD546 growth ratio. At 48 h, the values for Sm1321 and 
Sm1326 were 0.747±0.110 and 0.452±0.107, respectively, 
showing a better adherence proficiency for Sm1321 in spite 
of its poor growth. We do not rule out the possibility that 
reduced biofilm formation in the studied CF isolates could 
Fig. 2. (a) Bacterial growth (left panel) and biofilm biomass (right panel) of sequential S. maltophilia isolates cultured 
statically in TSB at 35 °C was determined in microtitre plates at 24 and 48 h by measuring the OD
546
 of the culture and of the CV 
dissolved in ethanol, respectively. ODc, cut- off, defined as three standard deviations above the mean OD of the negative 
control. Results are expressed as the mean±standard deviation of one of three representative experiments carried out in 
octuplicate. S. maltophilia K279a was used as a control. (b) Screening of RpfC–RpfF1 and RpfC–RpfF2 quorum- sensing variants.  
S. maltophilia K279a (RpfC–RpfF1 variant) and S. maltophilia D457 (RpfC–RpfF2 variant) were used as positive controls.
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be associated with a growth defect. However, since biofilm 
formation is a multifactorial process, the superior adherence 
proficiency of Sm1321 despite its deficiency in bacterial 
growth suggests that other factors are also involved. It is worth 
noting that different studies reported that non- CF strains 
are significantly more efficient than CF strains in forming 
biofilms [44, 45]
Fig.  3a shows that none of the isolates had the ability to 
move via swimming or twitching, motilities that have been 
involved in biofilm formation [10, 11]. The mean diameter 
of the swimming zones for the positive control K279a was 
9.29±0.26 mm. Regarding twitching motility, only K279a 
formed a hazy growth surrounding the colony and the mean 
diameter of the twitching zones, visualized by CV staining, 
was 15.13±0.90 mm. There were also striking differences 
between the adherence patterns. K279a showed a doughnut- 
shaped adherent zone, whereas the CF isolates remained 
adhered near the stab inoculation point.
The absence of swimming and twitching motilities has 
previously been reported in CF and non- CF S. maltophilia 
clinical isolates [25]. Accordingly, we have recently advised, 
in a congress oral presentation, that S. maltophilia isolates 
recovered from chronically colonized paediatric patients with 
CF in Argentina differed in some phenotypic traits, and some 
of them were non- biofilm producers and did not show the 
ability to move via swimming or twitching [29, 46].
Some strains of S. maltophilia such as K279a have a membrane- 
bound nitrate reductase, and it has been proposed that growth 
potential under microoxic conditions increase the ability to 
form biofilms [27]. In this study K279a was used as a control 
and presented nitrate reduction activity in the API 20NE 
system and amplified the 623 bp fragment corresponding to 
narG by PCR. By contrast, no nitrate reduction activity was 
detected in the studied isolates and, accordingly, the PCR for 
narG rendered negative results (Fig. S2). In a previous study 
of 63 S. maltophilia isolates from patients exposed to invasive 
devices in a university hospital in Argentina we detected 26 
isolates with no nitrate reduction activity and negative PCR 
for narG [36].
The major extracellular protease StmPr1 has been proposed as 
a relevant virulence factor for S. maltophilia [12]. None of the 
isolates showed proteolytic activity after 24–48 h of incuba-
tion, but, in contrast, at 24 h, K279a showed strong proteolytic 
activity. However, after 72 h of incubation Sm1321, Sm1336, 
Sm1340 and Sm1342 showed weak exoenzyme activity with 
zones of proteolysis ranging from 4.99 to 2.89 mm, while 
the mean value for K279a was 18.03 mm (Table 3). Accord-
ingly, these isolates, as well as K279a, amplified the 1621 bp 
fragment corresponding to the stmPr1 gene, which encodes 
the major alkaline serine protease, and the 570 bp fragment 
corresponding to the stmPr2 gene, by PCR (Table  3, Fig. 
S2). Isolates Sm1318 and Sm1326 also amplified both genes 
Fig. 3. Motility and siderophores assays of sequential S. maltophilia isolates. (a) Twitching motility (left panel). Twitching plates were 
inoculated to the bottom of the Petri plate and incubated at 35 °C for 48 h. Then, the agar was removed, the plate was stained with CV and 
twitching activity was measured in millimetres. Swimming motility (right panel). Isolates were surface- inoculated on swimming agar 
and, after incubation at 30 °C for 24 h, the growth zone was measured in millimetres. (b) Siderophore production was determined by the 
modified chrome azurol S (CAS) agar assay and recorded as the diameter of the orange halo produced by the colony after incubation at 
35 °C for 48 h. S. maltophilia K279a was used as a positive control in all assays.
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(Fig. S2) but scored negative for protease activity, suggesting 
the presence of mutations in these genes similar to those 
previously reported [12]. On the other hand, isolates Sm1346 
and Sm1347 were non- proteolytic and failed to amplify the 
stmPr1 and stmPr2 genes (Fig. S2).
Siderophores are important virulence factors, since they 
allow micro- organisms to survive in the host. When grown 
on modified CAS agar plates, only the first three sequential 
S. maltophilia isolates were CAS- positive for siderophore 
production (Table  3). They were classified as moderate 
(Sm1318) and weak siderophore producers (Sm1321 and 
Sm1326). As previously reported, the reference strain K279a 
showed strong siderophore production [13].
Sensitivity to oxidative stress, a relevant determinant for 
bacterial survival, was evaluated using the hydrogen peroxide 
disc assay. Based on the diameters of the growth inhibition 
zones, two different groups were identified among the S. malt-
ophilia isolates: one of them (Sm1318, Sm1321, Sm1326 and 
Sm1336, as well as K279a) exhibited high resistance, while 
the other (Sm1340, Sm1342, Sm1346 and Sm1347) showed 
moderate resistance (Table 3). Thus, a sequential evolution 
from high to moderate resistance over time was detected.
Screening of RpfC–RpfF clusters and dSF 
production
In this study, the presence of the RpfC–RpfF1 and RpfC–
RpfF2 variants was investigated by PCR using the primers 
shown in Table 2. All of the S. maltophilia isolates, as well as 
K279a, amplified the 1019 bp fragment corresponding to the 
RpfC–RpfF1 variant (Fig. 2b). Furthermore, extracts from 
culture supernatants of all isolates restored the endoglucanase 
activity of the rpfF mutant Xcc 8523, indicating DSF produc-
tion. Interestingly, Table 3 shows that the first three CF isolates 
(Sm1318, Sm1321 and Sm1326) produced similar concentra-
tions of DSF to those of K279a, within a range of 11.19 to 
11.77 endoglucanase units. On the other hand, the last five CF 
isolates produced significantly higher concentrations of DSF 
(P<0.001), especially Sm1346 and Sm1347 (14.33±0.55 and 
16.43±0.68 U, respectively).
Huedo et al. suggested that the QS signalling of RpfC–RpfF1 
strains has a positive role in biofilm formation [15]. Accord-
ingly, in a recent paper, we presented results that provided 
evidence for the positive role of DSF from the RpfC–RpfF1 
variant K279a in biofilm formation, swimming and twitching 
motilities, and siderophore production, as well as resistance 
to oxidative stress [47]. Even though the eight RpfC–RpfF1 
CF isolates produced DSF, they were non- motile and only 
Sm1321 and Sm1326 formed weak biofilms. Furthermore, 
siderophore production was only detected in the first three 
isolates and resistance to hydrogen peroxide decreased over 
time, since the first four isolates exhibited high resistance, 
while the last four showed moderate resistance. These 
features could be associated with the high amounts of DSF 
produced by the last five isolates. Torres et al. [48] demon-
strated that DSF synthesis in X. campestris has to be finely 
controlled to form structured biofilms, since a DSF over-
producer mutant formed only unstructured arrangements 
of bacteria.
Table 3. Protease, siderophore and DSF production, and stress oxidative resistance





(U endoglucanase activity)Enzyme activity
(mm)
stmPr1 gene stmPr2 gene
K279a 18.03±0.17 + + (S) 11.2±0.2 (HR) 13.62±0.28 11.77±0.73
Sm1318 0 + + (S) 10.4±0.7 (HR) 15.43±0.49 11.54±0.71
Sm1321 2.89±0.08 + + (W) 5.5±0.4 (HR) 14.42±0.29 11.20±1.02
Sm1326 0 + + (W) 4.5±0.1 (HR) 14.70±0.48 11.19±0.77
Sm1336 2.97±0.06 + + 0 (HR) 15.31±0.21 13.42±0.26
Sm1340 2.89±0.07 + + 0 (MR) 17.42±0.44 13.82±0.42
Sm1342 4.99±0.02 + + 0 (MR) 16.48±0.30 12.78±0.64
Sm1346 0 − − 0 (MR) 16.89±0.38 14.33±0.55
Sm1347 0 − − 0 (MR) 16.67±0.46 16.43±0.68
The proteolytic activity on nutrient agar supplemented with 1 % skimmed milk powder was measured after 72 h of incubation. The presence of 
stmPr1 and stmPr2 genes was tested by PCR. Siderophore production was visualized as an orange halo produced by the colony on modified CAS 
agar. Each isolate was classified as a weak (W, 4.0–5.9 mm), moderate (M, 6.0–8.9 mm) or strong siderophore producer (S,>9 mm). Sensitivity to 
hydrogen peroxide was determined as zones of growth inhibition surrounding each disc after 24 h of incubation. The resistance of each isolate 
to hydrogen peroxide was classified as low (LR, >18 mm), moderate (MR, 16–18 mm) or high (HR, <16 mm). DSF production was assayed by 
measuring the restoration of endoglucanase activity to the rpfF mutant Xcc 8523 by extracts from culture supernatants of S. maltophilia isolates. 
Diameters of zones of carboxymethyl cellulose hydrolysis were converted to relative endoglucanase units with a standard of cellulase I. All 
assays were conducted as described in in the Methods section and S. maltophilia K279a was used as a control.
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The described virulence phenotypic changes were observed 
in CF isolates recovered longitudinally, which, with the 
exception of Sm1326, belong to two related clones (Fig. 1). 
However, isolates of the same clone did not share the same 
virulence/resistance pattern. It is known that different 
populations of the same clone can evolve in the CF lung, 
given that they are exposed to a difficult environment and 
repeated antibiotic treatments that favour the emergence of 
mutant phenotypes [25]. In the present study, based on the 
spontaneous rifampicin- resistant mutation frequency, CF 
isolates were classified as strong mutators, weak mutators 
and normomutators, and a decreased mutation rate tendency 
was observed over time. Furthermore, Sm1340 and Sm1342 
presented indistinguishable PFGE profiles but different 
API20NE biocodes, mutation frequency and susceptibility 
to SXT and levofloxacin (Table 1). These findings are in agree-
ment with another report on the small relationship between 
S. maltophilia genotypes and observed phenotypes, including 
susceptibility to antibiotics, which suggests the existence of 
complex regulatory mechanisms that need to be investigated 
[3].
There is currently no consensus on the management of 
patients with CF and S. maltophilia- positive cultures. In some 
cases of exacerbation or chronic colonization/infection these 
patients are treated with antibiotics, but without consensus 
on the optimal regimen [49]. In a recent single‐centre US 
cohort study, 44 % of 88 patients who had a positive culture 
for S. maltophilia developed chronic infection, a result in 
accordance with that described by Barsky et al. [50]. Thus, 
as previously suggested, randomized controlled trials are 
needed to determine the effectiveness of antibiotic treatment 
for S. maltophilia infection in people with CF. Furthermore, 
approaches for eradication as well as those recommended for 
initial P. aeruginosa infection might be investigated [49, 50].
The limitations of our study include having considered 
only one chronically colonized patient and analysed only 
one colony from each clinical specimen at each different 
time point, which underestimates the heterogeneity of 
S. maltophilia in the CF airways at each sampling moment. 
Analysis of the intra- host evolution of multiple isolates 
of S. maltophilia represents a more appropriate way to 
address the complexity of the adaptation of CF pathogens 
thoroughly. However, several studies that analyse pathogens 
in the setting of CF have used the one isolate per sample 
model [26, 51]. We have initiated the study of S. maltophilia 
isolates from chronically colonized paediatric patients 
with CF from different hospitals of Argentina in order to 
evaluate genotypic and phenotypic adaptations involved in 
the progression from acute to chronic colonization.
ConCLuSIon
The present study shows the long- time persistence of two 
related S. maltophilia clones in an adult female with CF. 
During the adaptation of the prevalent clones to the CF lungs 
over time, we identified a gradual loss of virulence factors that 
could be associated with the high quantities of DSF produced 
by the evolved isolates. Further, a decreased mutation rate was 
observed in the late isolates. The role of all these adaptations 
over time remains to be elucidated from a clinical perspective, 
probably focusing on the damage they can cause to CF lungs.
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